← Leaderboards
Laura Clamon Schulz
Boston University
$3,083,984
Attributed
$6,388,530
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,388,530 · 8
By mechanism
R01$4,539,034 · 2
R00$742,573 · 1
R21$410,757 · 1
R56$217,371 · 1
K99$179,530 · 1
R03$158,565 · 1
Top collaborators
- Robert Michael Roberts8 shared
- Danny J Schust8 shared
- Toshihiko Ezashi5 shared
- Charlotte L Phillips2 shared
- Arin Kettle Oestreich1 shared
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyPlacentaPlacentationTrophoblastMothersCellsAffectStem CellsUterusSyncytiotrophoblastGiant CellsEmbryoFetalEnvironmentSignal TransductionPre-EclampsiaPhysiologicalImplantationInvadedFirst Pregnancy TrimesterPathway InteractionsPregnancy ComplicationsFetusInnovation
Grant awards (23)
Preclinical Testing of Early Life Anti-Myostatin Therapy for Osteogenesis$652,723
R01 · FY2025 · HD
Modeling Normal and Abnormal Trophoblasts$607,136
R01 · FY2025 · HD · contact PI
Modeling Normal and Abnormal Trophoblasts$606,395
R01 · FY2024 · HD · contact PI
Modeling Normal and Abnormal Trophoblasts$634,720
R01 · FY2023 · HD · contact PI
Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta$217,371
R56 · FY2023 · HD
Modeling normal and abnormal trophoblasts$358,551
R01 · FY2022 · HD
Effect of Gestational Diabetes on Placental Development$79,515
R03 · FY2022 · HD · contact PI
Modeling normal and abnormal trophoblasts$358,551
R01 · FY2021 · HD
Effect of Maternal Myostatin on Placental Support of Fetal Growth$184,303
R21 · FY2021 · HD · contact PI
Effect of Gestational Diabetes on Placental Development$79,050
R03 · FY2021 · HD · contact PI
Modeling normal and abnormal trophoblasts$407,227
R01 · FY2020 · HD
Effect of Maternal Myostatin on Placental Support of Fetal Growth$226,454
R21 · FY2020 · HD · contact PI
Modeling normal and abnormal trophoblasts$450,099
R01 · FY2019 · HD
Modeling normal and abnormal trophoblasts$463,632
R01 · FY2018 · HD
The Role of Leptin in Placental Development$241,661
R00 · FY2011 · HD · contact PI
The Role of Leptin in Placental Development$251,580
R00 · FY2010 · HD · contact PI
The Role of Leptin in Placental Development$249,332
R00 · FY2010 · HD · contact PI
The Role of Leptin in Placental Development$89,530
K99 · FY2009 · HD · contact PI
The Role of Leptin in Placental Development$90,000
K99 · FY2008 · HD · contact PI
Effect of Leptin on Trophoblast Invasiveness$50,428
F32 · FY2006 · HD · contact PI
Effect of Leptin on Trophoblast Invasiveness$28,180
F32 · FY2005 · HD
Effect of Leptin on Trophoblast Invasiveness$19,116
F32 · FY2005 · HD
Effect of Leptin on Trophoblast Invasiveness$42,976
F32 · FY2004 · HD